Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 26, Issue 10, Pages 1383-1390
Publisher
SAGE Publications
Online
2012-06-14
DOI
10.1177/0269881112449397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Varenicline on Smoking Cue–Triggered Neural and Craving Responses
- (2011) Teresa Franklin et al. ARCHIVES OF GENERAL PSYCHIATRY
- Use of Varenicline for 4 Weeks Before Quitting Smoking
- (2011) Peter Hajek et al. ARCHIVES OF INTERNAL MEDICINE
- Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level
- (2011) A. A. Strasser et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Effects of Extended Pre-Quit Varenicline Treatment on Smoking Behavior and Short-Term Abstinence: A Randomized Clinical Trial
- (2011) L W Hawk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
- (2011) Rebecca L. Ashare et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
- (2011) S. Rennard et al. NICOTINE & TOBACCO RESEARCH
- Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial
- (2011) J. R. Hughes et al. NICOTINE & TOBACCO RESEARCH
- Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior
- (2011) Jed E. Rose PSYCHOPHARMACOLOGY
- Varenicline effects on craving, cue reactivity, and smoking reward
- (2011) Thomas H. Brandon et al. PSYCHOPHARMACOLOGY
- Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC–MS
- (2011) Kannan Rangiah et al. Bioanalysis
- Parallel Anxiolytic-Like Effects and Upregulation of Neuronal Nicotinic Acetylcholine Receptors Following Chronic Nicotine and Varenicline
- (2010) J. R. Turner et al. NICOTINE & TOBACCO RESEARCH
- Varenicline’s effects on acute smoking behavior and reward and their association with subsequent abstinence
- (2010) Kenneth A. Perkins et al. PSYCHOPHARMACOLOGY
- Time to First Cigarette after Waking Predicts Cotinine Levels
- (2009) J. E. Muscat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Behavioral filter vent blocking on the first cigarette of the day predicts which smokers of light cigarettes will increase smoke exposure from blocked vents.
- (2009) Andrew A. Strasser et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Subjective responses to intravenous nicotine: Greater sensitivity in women than in men.
- (2009) Mehmet Sofuoglu et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans
- (2009) Mehmet Sofuoglu et al. PSYCHOPHARMACOLOGY
- Nicotine patch therapy prior to quitting smoking: a meta-analysis
- (2008) Saul Shiffman et al. ADDICTION
- Varenicline Improves Mood and Cognition During Smoking Abstinence
- (2008) Freda Patterson et al. BIOLOGICAL PSYCHIATRY
- Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion
- (2008) F Patterson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started